A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.

BC Kuenen; P.O. Witteveen; G. Giaccone; A. Dontabhaktuni; F. Fox; T. Katz; H. Youssoufian; J. Zhu; E.K. Rowinsky; E.E. Voest

A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.

BC Kuenen, P.O. Witteveen, G. Giaccone, A. Dontabhaktuni, F. Fox, T. Katz, H. Youssoufian, J. Zhu, E.K. Rowinsky, E.E. Voest

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1915-1923
Number of pages	9
Journal	Clinical Cancer Research
Volume	16
Issue number	6
Publication status	Published - 2010

Cite this

@article{3c6409614f534ed485df234eb9c20c41,

title = "A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.",

author = "BC Kuenen and P.O. Witteveen and G. Giaccone and A. Dontabhaktuni and F. Fox and T. Katz and H. Youssoufian and J. Zhu and E.K. Rowinsky and E.E. Voest",

year = "2010",

language = "English",

volume = "16",

pages = "1915--1923",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

TY - JOUR

T1 - A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.

AU - Kuenen, BC

AU - Witteveen, P.O.

AU - Giaccone, G.

AU - Dontabhaktuni, A.

AU - Fox, F.

AU - Katz, T.

AU - Youssoufian, H.

AU - Zhu, J.

AU - Rowinsky, E.K.

AU - Voest, E.E.

PY - 2010

Y1 - 2010

M3 - Article

SN - 1078-0432

VL - 16

SP - 1915

EP - 1923

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 6

ER -